You are here

skin cancer

DermaSensor’s skin cancer detection device helps clinicians in published study

Clinical Trials Arena

Fri, 09/20/24 - 11:08 am

artificial intelligence

Moderna-Merck skin cancer vaccine shows survival benefit in long-term follow-up

Reuters

Mon, 06/3/24 - 11:58 am

Moderna Therapeutics

Merck stops testing combo drug for skin cancer as more patients discontinue

Reuters

Mon, 05/13/24 - 11:14 am

clinical trials

FDA clears DermaSensor's AI-powered skin cancer detecting device

Reuters

Wed, 01/17/24 - 09:24 am

artificial intelligence

Moderna/Merck begins late-stage study of skin cancer vaccine combination

Yahoo/Reuters

Wed, 07/26/23 - 09:36 am

Moderna Therapeutics

clinical trials

Cancer vaccines poised to unlock 'new treatment paradigm' with Merck/Moderna data

Yahoo/Reuters

Tue, 06/6/23 - 10:04 am

Moderna Therapeutics

Turn Therapeutics Announces Positive In-Vivo Data for Non-Melanoma Skin Cancer Candidate

BioSpace

Wed, 07/13/22 - 10:10 am

Turn Therapeutics

clinical trials

basal cell carcinoma

Sanofi and Immunocore Pair High Potential Molecules for Metastatic Skin Cancers

BioSpace

Sun, 06/5/22 - 11:31 pm

clinical trials

Regeneron sees skin cancer potential beyond PD-1s with $250M Checkmate acquisition

Fierce Biotech

Tue, 04/19/22 - 11:10 am

Checkmate Pharmaceuticals

This Medical Device Company Is Changing the Game in Skin Cancer

Motley Fool

Sun, 07/18/21 - 09:47 pm

Replimune heads for the liver

EP Vantage

Fri, 06/4/21 - 10:39 am

oncolytic viruses

Bristol Myers details data for closely watched cancer immunotherapy

BioPharma Dive

Wed, 05/19/21 - 11:27 pm

Bristol Myers Squibb

Sanofi/Regeneron's Libtayo Wins FDA Approval For A Type Of Skin Cancer

Yahoo/Benzinga

Wed, 02/10/21 - 10:32 am

advanced basal cell carcinoma

Sanofi/Regeneron’s Libtayo set for new skin cancer use

Pharmaforum

Fri, 09/18/20 - 10:40 am

clinical trials

Blow for Novartis as PD-1 drug spartalizumab flunks trial

Pharmaforum

Sun, 08/23/20 - 06:28 pm

clinical trials

Sanofi and Regeneron's I-O med Libtayo, on a roll, puts up basal cell carcinoma win

Fierce Pharma

Tue, 05/5/20 - 12:59 pm

basal cell carcinoma

clinical trials

Almirall strikes option deal to buy Bioniz and dermatology drug BNZ-1

Pharmaforum

Wed, 01/8/20 - 11:36 pm

An immuno-oncology triplet from Roche shows promise in mouse models of several tumors

Fierce Biotech

Fri, 01/3/20 - 09:44 am

targeted antibodies

Regeneron, Sanofi Win Approval for Their First Immuno-Oncology Drug

Bloomberg

Sat, 09/29/18 - 12:12 pm

immuno-oncology

Biofrontera files for IPO to run skin cancer clinical trials

Fierce Biotech

Mon, 01/15/18 - 10:36 am

clinical trials

Pages